Bold Reforms Needed for India’s Vaccine Industry To Boom - McKinsey
This article was originally published in PharmAsia News
Executive Summary
Pushed by an expanded immunization program and a steady flow of new generation vaccines, India’s vaccine industry could grow to $1.65 billion if projected scenarios unfold.